Abstract Early-onset progressive encephalopathy is a lethal encephalopathy caused by NAXE gene mutations. This paper reports the clinical and genetic features of a patient with early-onset progressive encephalopathy. A 4-yearold boy admitted to the hospital had repeated walking instability and limb weakness for 2 years. The patient and his elder brother (already dead) had clinical onset at 2 years of age. Both of them showed symptoms such as strabismus, ataxia, reduced muscle tone, delayed development, and repeated respiratory failure after infection. The NAXE gene of the patient showed new compound heterozygous mutations, i.e., c.255 (exon 2) A > T from his mother and c.361 (exon 3) G>A from his father. The NAXE gene encodes an epimerase that is essential for the repair of cellular metabolites of NADHX and NADPHX. This disease is associated with a defciency of the mitochondrial NAD(P)HX repair system. Patients usually have rapid disease progression. They are also quite likely to have respiratory failure immediately after infection.
YU Dan,ZHAO Fu-Min,CAI Xiao-Tang et al. Clinical and genetic features of early-onset progressive encephalopathy associated with NAXE gene mutations[J]. CJCP, 2018, 20(7): 524-528.
YU Dan,ZHAO Fu-Min,CAI Xiao-Tang et al. Clinical and genetic features of early-onset progressive encephalopathy associated with NAXE gene mutations[J]. CJCP, 2018, 20(7): 524-528.
Marbaix AY, Noël G, Detroux AM, et al. Extremely conserved ATP-or ADP-dependent enzymatic system for nicotinamide nucleotide repair[J]. Biol Chem, 2011, 286(48):41246-41252.
[2]
Marbaix AY, Tyteca D, Niehaus TD, et al. Occurrence and subcellular distribution of the NADPHX repair system in mammals[J]. Biochem, 2014, 460(1):49-58.
[3]
Prabhakar P, Laboy JI, Wang J, et al. Effect of NADH-X on cytosolic glycerol-3-phosphate dehydrogenase[J]. Arch Biochem Biophys, 1998, 360(2):195-205.
[4]
Kremer LS, Danhauser K, Herebian D, et al. NAXE mutations disrupt the cellular NAD(P)HX repair system and cause a lethal neurometabolic disorder of early childhood[J]. Am J Hum Genet, 2016, 99(4):894-902.
[5]
Sorci-Thomas MG, Thomas MJ. AIBP, NAXE, and angiogenesis:What's in a name?[J]. Circ Res, 2017, 120(11):1690-1691.
[6]
Kremer LS, Danhauser K, Herebian D, et al. NAXE mutations disrupt the cellular NAD (P)HX repair system and cause a lethal neurometabolic disorder of early childhood[J]. Am J Hum Genet, 2016, 99(4):894-902.
[7]
Spiegel R, Shaag A, Shalev S, et al. Homozygous mutation in the APOA1BP is associated with a lethal infantile leukoencephalopathy[J]. Neurogenetics, 2016, 17(3):187-190.
